Methodology for clinical trials in cancer patients with febrile neutropenia Ronald Feld EDITORIAL Pages: 423 - 424
Palliative care in Italy: the current situation A. SbanottoRuth Burnhill SUPPORTIVE CARE INTERNATIONAL Pages: 426 - 429
Cancer pain management in developing countries: a mosaic of complex issues resulting in inadequate analgesia Rachel C. KoshyDeborah RhodesS. A. Grossman SPECIAL ARTICLE Pages: 430 - 437
Statistical considerations in clinical trials testing empiric antibiotic regimens in patients with febrile neutropenia Marianne Paesmans REVIEW ARTICLE Pages: 438 - 443
Criteria for response in patients in clinical trials of empiric antibiotic regimens for febrile neutropenia. Is there agreement? Ronald Feld REVIEW ARTICLE Pages: 444 - 448
Empiric therapy for the febrile neutropenic patient Stephen C. Schimpff REVIEW ARTICLE Pages: 449 - 456
Stratification in clinical trials of febrile neutropenia Linda S. Elting REVIEW ARTICLE Pages: 457 - 461
Effect of carboplatin on response and palliation in hormone-refractory prostate cancer W. F. JungiJürg Bernhard for the Swiss Group for Clinical Cancer Research (SAKK) ORIGINAL ARTICLE Pages: 462 - 468
Tetanus immunity in patients with hematological malignancies V. HamarströmK. PauksenP. Ljungman ORIGINAL ARTICLE Pages: 469 - 472
Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting J. B. WhitmoreMark G. KrisWilliam F. Hahne ORIGINAL ARTICLE Pages: 473 - 478
Competent gastrostomy for patients with head and neck cancer P. P. VassilopoulosE. FilopoulosG. Plataniotis SHORT COMMUNICATION Pages: 479 - 481
Opioid responsiveness in patients with advanced head and neck cancer Sebastiano Mercadante SHORT COMMUNICATION Pages: 482 - 485
